| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 95 | 2026 | 290 | 23.560 |
Why?
|
| Staphylococcal Infections | 66 | 2026 | 286 | 13.570 |
Why?
|
| Bacterial Proteins | 74 | 2026 | 899 | 10.750 |
Why?
|
| Bacillus anthracis | 27 | 2023 | 73 | 6.360 |
Why?
|
| Cell Wall | 27 | 2026 | 72 | 6.340 |
Why?
|
| Staphylococcal Protein A | 23 | 2026 | 44 | 6.250 |
Why?
|
| Gene Expression Regulation, Bacterial | 34 | 2025 | 210 | 4.680 |
Why?
|
| Antibodies, Bacterial | 20 | 2026 | 106 | 4.600 |
Why?
|
| Peptidoglycan | 13 | 2021 | 30 | 4.470 |
Why?
|
| Coagulase | 18 | 2025 | 29 | 3.100 |
Why?
|
| Polysaccharides, Bacterial | 8 | 2025 | 34 | 3.000 |
Why?
|
| Teichoic Acids | 9 | 2024 | 18 | 2.710 |
Why?
|
| Virulence Factors | 16 | 2026 | 117 | 2.610 |
Why?
|
| Antibodies, Monoclonal | 10 | 2025 | 1415 | 2.390 |
Why?
|
| Type VII Secretion Systems | 4 | 2026 | 4 | 2.080 |
Why?
|
| Protein Transport | 16 | 2026 | 448 | 2.040 |
Why?
|
| Staphylococcal Vaccines | 8 | 2019 | 17 | 1.870 |
Why?
|
| Escherichia coli | 23 | 2005 | 571 | 1.830 |
Why?
|
| Gram-Positive Bacteria | 4 | 2019 | 19 | 1.750 |
Why?
|
| Protein Sorting Signals | 7 | 2025 | 42 | 1.700 |
Why?
|
| Membrane Proteins | 16 | 2019 | 1285 | 1.670 |
Why?
|
| Phagocytosis | 6 | 2025 | 117 | 1.610 |
Why?
|
| Lipopolysaccharides | 8 | 2024 | 312 | 1.590 |
Why?
|
| Genes, Bacterial | 17 | 2017 | 150 | 1.540 |
Why?
|
| Bacteremia | 6 | 2016 | 111 | 1.530 |
Why?
|
| Animals | 84 | 2026 | 28864 | 1.420 |
Why?
|
| Membrane Glycoproteins | 9 | 2022 | 446 | 1.370 |
Why?
|
| Antigens, Bacterial | 10 | 2024 | 135 | 1.330 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 7 | 2024 | 86 | 1.310 |
Why?
|
| Adenosine Triphosphatases | 6 | 2025 | 141 | 1.290 |
Why?
|
| Mice | 53 | 2026 | 12682 | 1.270 |
Why?
|
| Abscess | 13 | 2016 | 94 | 1.260 |
Why?
|
| Aminoacyltransferases | 7 | 2019 | 10 | 1.240 |
Why?
|
| Mice, Inbred BALB C | 27 | 2021 | 1110 | 1.200 |
Why?
|
| Polysaccharides | 6 | 2026 | 99 | 1.180 |
Why?
|
| Immune Evasion | 6 | 2021 | 37 | 1.180 |
Why?
|
| Sigma Factor | 10 | 2005 | 23 | 1.180 |
Why?
|
| Cysteine Endopeptidases | 7 | 2019 | 89 | 1.160 |
Why?
|
| von Willebrand Factor | 8 | 2021 | 43 | 1.140 |
Why?
|
| Vaccines | 3 | 2022 | 86 | 1.090 |
Why?
|
| Cell Membrane | 10 | 2019 | 673 | 0.970 |
Why?
|
| Mutagenesis, Insertional | 9 | 2014 | 103 | 0.960 |
Why?
|
| Virulence | 16 | 2024 | 279 | 0.950 |
Why?
|
| Mutation | 29 | 2025 | 4389 | 0.940 |
Why?
|
| Immunoglobulin A | 2 | 2026 | 94 | 0.940 |
Why?
|
| Sepsis | 4 | 2023 | 426 | 0.880 |
Why?
|
| Protein Multimerization | 5 | 2025 | 194 | 0.880 |
Why?
|
| Anthrax | 6 | 2023 | 31 | 0.860 |
Why?
|
| Transcription Factors | 10 | 2014 | 1711 | 0.860 |
Why?
|
| Galactose | 3 | 2026 | 29 | 0.840 |
Why?
|
| Host-Pathogen Interactions | 6 | 2019 | 249 | 0.840 |
Why?
|
| Amino Acid Sequence | 24 | 2022 | 2005 | 0.820 |
Why?
|
| SEC Translocation Channels | 5 | 2025 | 15 | 0.790 |
Why?
|
| Antibodies, Neutralizing | 7 | 2025 | 173 | 0.770 |
Why?
|
| Immunoglobulin G | 4 | 2026 | 480 | 0.770 |
Why?
|
| Escherichia coli Proteins | 10 | 2002 | 184 | 0.760 |
Why?
|
| Superantigens | 2 | 2021 | 24 | 0.760 |
Why?
|
| Disease Models, Animal | 17 | 2026 | 2570 | 0.750 |
Why?
|
| Disulfides | 8 | 2002 | 66 | 0.740 |
Why?
|
| Protein Binding | 13 | 2026 | 1554 | 0.710 |
Why?
|
| Protein Folding | 13 | 2002 | 291 | 0.710 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 4 | 2018 | 11 | 0.690 |
Why?
|
| Protein Engineering | 3 | 2022 | 159 | 0.680 |
Why?
|
| Protein Disulfide-Isomerases | 10 | 2002 | 17 | 0.670 |
Why?
|
| Fibrin | 5 | 2019 | 86 | 0.660 |
Why?
|
| Hydrolases | 2 | 2026 | 30 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 16 | 2026 | 3591 | 0.640 |
Why?
|
| Gene Deletion | 10 | 2020 | 353 | 0.640 |
Why?
|
| Staphylococcal Skin Infections | 3 | 2022 | 25 | 0.630 |
Why?
|
| Soft Tissue Infections | 3 | 2022 | 28 | 0.630 |
Why?
|
| Humans | 57 | 2026 | 97913 | 0.620 |
Why?
|
| Serine | 1 | 2020 | 105 | 0.620 |
Why?
|
| Bacterial Adhesion | 6 | 2021 | 84 | 0.610 |
Why?
|
| Agglutination | 4 | 2016 | 16 | 0.600 |
Why?
|
| Carrier Proteins | 10 | 2021 | 666 | 0.600 |
Why?
|
| Chromatography, Gel | 2 | 2019 | 96 | 0.580 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2019 | 2 | 0.580 |
Why?
|
| Hydrofluoric Acid | 1 | 2019 | 5 | 0.580 |
Why?
|
| Spores, Bacterial | 2 | 2015 | 18 | 0.550 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 330 | 0.550 |
Why?
|
| Immune Tolerance | 2 | 2021 | 385 | 0.550 |
Why?
|
| Molecular Sequence Data | 24 | 2016 | 2896 | 0.540 |
Why?
|
| Neutrophils | 6 | 2022 | 344 | 0.530 |
Why?
|
| Deoxyribonucleases | 2 | 2016 | 27 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 8 | 2024 | 880 | 0.520 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 726 | 0.510 |
Why?
|
| Cell Division | 6 | 2024 | 689 | 0.500 |
Why?
|
| Staphylococcus | 1 | 2016 | 24 | 0.500 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 73 | 0.490 |
Why?
|
| Genetic Techniques | 2 | 2008 | 74 | 0.490 |
Why?
|
| Protein Structure, Tertiary | 12 | 2016 | 731 | 0.480 |
Why?
|
| Extracellular Traps | 3 | 2022 | 16 | 0.480 |
Why?
|
| Secretory Pathway | 2 | 2013 | 23 | 0.480 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2015 | 215 | 0.470 |
Why?
|
| Multigene Family | 5 | 2018 | 204 | 0.470 |
Why?
|
| Glycosylation | 4 | 2026 | 141 | 0.470 |
Why?
|
| Heat-Shock Proteins | 6 | 1997 | 178 | 0.470 |
Why?
|
| Apoptosis | 3 | 2019 | 1750 | 0.470 |
Why?
|
| Endocarditis, Bacterial | 3 | 2022 | 38 | 0.470 |
Why?
|
| DNA Transposable Elements | 4 | 2014 | 170 | 0.440 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 895 | 0.430 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 169 | 0.420 |
Why?
|
| Leukopenia | 1 | 2014 | 66 | 0.420 |
Why?
|
| Ligases | 1 | 2014 | 44 | 0.410 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2026 | 42 | 0.410 |
Why?
|
| Glucosyltransferases | 1 | 2013 | 26 | 0.410 |
Why?
|
| Acetylglucosamine | 1 | 2013 | 18 | 0.410 |
Why?
|
| Adenosine | 3 | 2011 | 291 | 0.400 |
Why?
|
| Signal Transduction | 5 | 2019 | 3615 | 0.400 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 161 | 0.400 |
Why?
|
| Deoxyadenosines | 3 | 2019 | 23 | 0.390 |
Why?
|
| Bacterial Capsules | 3 | 2012 | 29 | 0.390 |
Why?
|
| Adaptive Immunity | 4 | 2021 | 193 | 0.390 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 39 | 0.380 |
Why?
|
| Rabbits | 8 | 2022 | 581 | 0.370 |
Why?
|
| Complement System Proteins | 3 | 2023 | 87 | 0.370 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2012 | 13 | 0.370 |
Why?
|
| Amino Acid Motifs | 5 | 2025 | 118 | 0.370 |
Why?
|
| Bacterial Secretion Systems | 1 | 2012 | 10 | 0.360 |
Why?
|
| Female | 30 | 2026 | 51441 | 0.360 |
Why?
|
| Nucleotidases | 1 | 2011 | 3 | 0.350 |
Why?
|
| Bacterial Outer Membrane Proteins | 5 | 2011 | 56 | 0.350 |
Why?
|
| Bacterial Toxins | 4 | 2023 | 113 | 0.350 |
Why?
|
| Phosphoglycerate Kinase | 7 | 1992 | 14 | 0.350 |
Why?
|
| Acetylglucosaminidase | 1 | 2011 | 5 | 0.340 |
Why?
|
| Antigenic Variation | 1 | 2011 | 29 | 0.340 |
Why?
|
| Yersinia pestis | 2 | 2022 | 24 | 0.340 |
Why?
|
| Plague | 2 | 2022 | 27 | 0.340 |
Why?
|
| Periplasmic Proteins | 5 | 1998 | 6 | 0.330 |
Why?
|
| Glycosyltransferases | 2 | 2022 | 20 | 0.330 |
Why?
|
| Viruses | 1 | 2011 | 64 | 0.330 |
Why?
|
| Cloning, Molecular | 12 | 2011 | 581 | 0.320 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 642 | 0.320 |
Why?
|
| Transcription, Genetic | 9 | 2006 | 1133 | 0.320 |
Why?
|
| Isomerases | 5 | 1996 | 9 | 0.310 |
Why?
|
| Plasmids | 6 | 2023 | 275 | 0.310 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2021 | 149 | 0.300 |
Why?
|
| Cytoplasm | 7 | 2003 | 276 | 0.300 |
Why?
|
| Kidney | 4 | 2022 | 1123 | 0.290 |
Why?
|
| Peptidyl Transferases | 1 | 2008 | 4 | 0.290 |
Why?
|
| Aminobenzoates | 1 | 2008 | 7 | 0.290 |
Why?
|
| Lipoproteins | 2 | 2006 | 136 | 0.290 |
Why?
|
| Caspase 3 | 2 | 2019 | 161 | 0.280 |
Why?
|
| Sulfides | 1 | 2008 | 72 | 0.280 |
Why?
|
| Regulon | 4 | 2001 | 17 | 0.280 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2019 | 18 | 0.270 |
Why?
|
| Sequence Deletion | 5 | 2015 | 207 | 0.270 |
Why?
|
| Mutagenesis | 3 | 2006 | 195 | 0.270 |
Why?
|
| Drug Resistance, Microbial | 3 | 2017 | 63 | 0.260 |
Why?
|
| Electron Transport | 4 | 2002 | 74 | 0.260 |
Why?
|
| Cell Line | 3 | 2020 | 2482 | 0.250 |
Why?
|
| Macrophages | 3 | 2019 | 641 | 0.250 |
Why?
|
| Transferases | 1 | 2006 | 19 | 0.250 |
Why?
|
| Receptors, IgG | 2 | 2026 | 70 | 0.250 |
Why?
|
| Aortic Valve | 2 | 2019 | 258 | 0.250 |
Why?
|
| Bacteria | 1 | 2011 | 543 | 0.250 |
Why?
|
| HEK293 Cells | 4 | 2022 | 720 | 0.240 |
Why?
|
| Immunity | 2 | 2022 | 159 | 0.240 |
Why?
|
| Guinea Pigs | 5 | 2023 | 162 | 0.240 |
Why?
|
| Hemolysin Proteins | 2 | 2019 | 32 | 0.240 |
Why?
|
| DNA-Directed RNA Polymerases | 3 | 2002 | 99 | 0.240 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2026 | 30 | 0.240 |
Why?
|
| Antibodies | 3 | 2019 | 349 | 0.230 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2019 | 52 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2022 | 86 | 0.230 |
Why?
|
| Trisaccharides | 2 | 2022 | 13 | 0.220 |
Why?
|
| Base Sequence | 11 | 2006 | 2222 | 0.220 |
Why?
|
| Cysteine | 4 | 2007 | 149 | 0.220 |
Why?
|
| Mice, Knockout | 3 | 2026 | 2206 | 0.220 |
Why?
|
| Sulfhydryl Compounds | 3 | 2008 | 67 | 0.210 |
Why?
|
| Models, Molecular | 7 | 2014 | 1390 | 0.210 |
Why?
|
| Polymers | 2 | 2022 | 225 | 0.200 |
Why?
|
| Serine Endopeptidases | 5 | 1996 | 154 | 0.200 |
Why?
|
| Complement Activation | 2 | 2022 | 88 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 1 | 2024 | 225 | 0.200 |
Why?
|
| Nitric Oxide Synthase | 1 | 2024 | 124 | 0.200 |
Why?
|
| Endothelium, Vascular | 2 | 2017 | 440 | 0.200 |
Why?
|
| Temperature | 2 | 2025 | 443 | 0.200 |
Why?
|
| Periplasmic Binding Proteins | 2 | 2000 | 24 | 0.190 |
Why?
|
| Culture Media | 2 | 2013 | 138 | 0.190 |
Why?
|
| Bacillus | 1 | 2023 | 11 | 0.190 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2000 | 76 | 0.190 |
Why?
|
| Polyglutamic Acid | 3 | 2015 | 15 | 0.190 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 5 | 0.190 |
Why?
|
| Saccharomyces cerevisiae | 6 | 1992 | 477 | 0.190 |
Why?
|
| Endocarditis | 1 | 2022 | 26 | 0.190 |
Why?
|
| Sugars | 1 | 2022 | 5 | 0.190 |
Why?
|
| Cell Death | 2 | 2021 | 257 | 0.190 |
Why?
|
| DNA, Ancient | 1 | 2022 | 22 | 0.190 |
Why?
|
| Models, Biological | 6 | 2014 | 1809 | 0.190 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2000 | 144 | 0.180 |
Why?
|
| Thioredoxins | 1 | 2002 | 12 | 0.180 |
Why?
|
| Catalytic Domain | 4 | 2021 | 164 | 0.180 |
Why?
|
| Blood Coagulation | 2 | 2013 | 90 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2002 | 31 | 0.180 |
Why?
|
| Vaccines, DNA | 1 | 2022 | 19 | 0.180 |
Why?
|
| Recombinant Proteins | 8 | 2019 | 993 | 0.180 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2022 | 43 | 0.180 |
Why?
|
| Protein Structure, Secondary | 5 | 2015 | 340 | 0.180 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 55 | 0.180 |
Why?
|
| Receptors, Fc | 1 | 2022 | 38 | 0.180 |
Why?
|
| Nucleic Acids | 1 | 2022 | 36 | 0.170 |
Why?
|
| Kinetics | 8 | 2011 | 1475 | 0.170 |
Why?
|
| Coronavirus OC43, Human | 1 | 2021 | 7 | 0.170 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 52 | 0.170 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2016 | 90 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 155 | 0.170 |
Why?
|
| Cross Reactions | 2 | 2019 | 115 | 0.170 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 56 | 0.160 |
Why?
|
| Thiazoles | 1 | 2021 | 126 | 0.160 |
Why?
|
| Arthritis, Infectious | 1 | 2020 | 19 | 0.160 |
Why?
|
| Mammals | 1 | 2023 | 268 | 0.160 |
Why?
|
| Immunoconjugates | 1 | 2021 | 138 | 0.160 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 106 | 0.160 |
Why?
|
| Genetic Complementation Test | 6 | 2014 | 84 | 0.160 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 821 | 0.160 |
Why?
|
| Binding Sites | 8 | 2017 | 1159 | 0.160 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2019 | 5 | 0.150 |
Why?
|
| Endophthalmitis | 1 | 2019 | 18 | 0.150 |
Why?
|
| Enzyme Activation | 2 | 2019 | 678 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 976 | 0.150 |
Why?
|
| Rickettsia conorii | 1 | 2019 | 4 | 0.150 |
Why?
|
| O Antigens | 1 | 2019 | 12 | 0.150 |
Why?
|
| Skin | 1 | 2023 | 592 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 338 | 0.150 |
Why?
|
| Iron | 3 | 2012 | 178 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2022 | 1527 | 0.150 |
Why?
|
| Streptococcal Vaccines | 1 | 2019 | 2 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2021 | 217 | 0.150 |
Why?
|
| Epithelium, Corneal | 1 | 2019 | 13 | 0.150 |
Why?
|
| Vaccines, Conjugate | 2 | 2016 | 9 | 0.150 |
Why?
|
| Chemical Fractionation | 1 | 2019 | 5 | 0.150 |
Why?
|
| Corneal Diseases | 1 | 2019 | 29 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2021 | 369 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 1996 | 125 | 0.140 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2019 | 83 | 0.140 |
Why?
|
| Carrier State | 1 | 2018 | 40 | 0.140 |
Why?
|
| Hydrolysis | 3 | 2011 | 145 | 0.140 |
Why?
|
| Nasopharynx | 1 | 2018 | 52 | 0.140 |
Why?
|
| Selection, Genetic | 1 | 2022 | 571 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 307 | 0.130 |
Why?
|
| DNA, Bacterial | 3 | 2008 | 236 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2022 | 1946 | 0.130 |
Why?
|
| Antibody Formation | 2 | 2016 | 172 | 0.130 |
Why?
|
| Endopeptidases | 2 | 2003 | 114 | 0.130 |
Why?
|
| Genome, Bacterial | 3 | 2012 | 144 | 0.130 |
Why?
|
| Regional Blood Flow | 2 | 2017 | 194 | 0.130 |
Why?
|
| Catheter-Related Infections | 2 | 2018 | 26 | 0.130 |
Why?
|
| Dipeptides | 2 | 2009 | 41 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 58 | 0.130 |
Why?
|
| Endopeptidase Clp | 1 | 1996 | 4 | 0.130 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 52 | 0.130 |
Why?
|
| Mesentery | 1 | 2017 | 49 | 0.130 |
Why?
|
| Consensus Sequence | 2 | 2013 | 64 | 0.120 |
Why?
|
| Chromatography, Affinity | 1 | 2016 | 73 | 0.120 |
Why?
|
| Adenosine Triphosphate | 3 | 2017 | 319 | 0.120 |
Why?
|
| Immunophilins | 1 | 1996 | 4 | 0.120 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1996 | 9 | 0.120 |
Why?
|
| Wound Healing | 1 | 2019 | 384 | 0.120 |
Why?
|
| Vaccines, Subunit | 1 | 2016 | 54 | 0.120 |
Why?
|
| Chromosome Mapping | 7 | 1997 | 1061 | 0.120 |
Why?
|
| Opsonin Proteins | 1 | 2016 | 6 | 0.120 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2016 | 12 | 0.120 |
Why?
|
| Hexosaminidases | 1 | 2016 | 6 | 0.120 |
Why?
|
| Homeostasis | 2 | 2016 | 474 | 0.120 |
Why?
|
| Substrate Specificity | 4 | 2014 | 374 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1997 | 159 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 831 | 0.120 |
Why?
|
| Oxidation-Reduction | 6 | 2002 | 419 | 0.120 |
Why?
|
| Models, Chemical | 4 | 2009 | 185 | 0.110 |
Why?
|
| Molecular Conformation | 2 | 2014 | 112 | 0.110 |
Why?
|
| Amino Acid Isomerases | 1 | 2015 | 5 | 0.110 |
Why?
|
| Immunoglobulin M | 2 | 2015 | 153 | 0.110 |
Why?
|
| Microbial Viability | 2 | 2012 | 34 | 0.110 |
Why?
|
| Adenosine Monophosphate | 2 | 2011 | 31 | 0.110 |
Why?
|
| Immunization, Passive | 2 | 2011 | 69 | 0.110 |
Why?
|
| Protein Disulfide Reductase (Glutathione) | 1 | 1994 | 1 | 0.110 |
Why?
|
| Hot Temperature | 4 | 2021 | 228 | 0.100 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 16 | 0.100 |
Why?
|
| Oxidoreductases | 4 | 1998 | 112 | 0.100 |
Why?
|
| Factor XIII | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 284 | 0.100 |
Why?
|
| Protein Conformation | 8 | 2007 | 923 | 0.100 |
Why?
|
| Prothrombin | 1 | 2013 | 19 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 79 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 250 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2013 | 48 | 0.100 |
Why?
|
| Macromolecular Substances | 1 | 2013 | 162 | 0.100 |
Why?
|
| Time Factors | 6 | 2019 | 5566 | 0.100 |
Why?
|
| Phosphatidylglycerols | 1 | 2013 | 4 | 0.100 |
Why?
|
| Preservation, Biological | 1 | 2013 | 5 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 2552 | 0.100 |
Why?
|
| Bacillus cereus | 1 | 2013 | 9 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 425 | 0.100 |
Why?
|
| Containment of Biohazards | 1 | 2013 | 9 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1118 | 0.100 |
Why?
|
| Thrombin | 1 | 2013 | 60 | 0.100 |
Why?
|
| Fibronectins | 1 | 2013 | 104 | 0.100 |
Why?
|
| Bacterial Vaccines | 1 | 2013 | 44 | 0.090 |
Why?
|
| Acetyltransferases | 1 | 2012 | 36 | 0.090 |
Why?
|
| Acyltransferases | 1 | 2013 | 57 | 0.090 |
Why?
|
| Peritonitis | 1 | 2012 | 28 | 0.090 |
Why?
|
| Anthrax Vaccines | 1 | 2012 | 2 | 0.090 |
Why?
|
| Research Design | 1 | 2016 | 658 | 0.090 |
Why?
|
| Polymerization | 1 | 2012 | 36 | 0.090 |
Why?
|
| Fimbriae, Bacterial | 1 | 2012 | 24 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 1992 | 480 | 0.090 |
Why?
|
| Ligands | 1 | 2013 | 486 | 0.090 |
Why?
|
| Proteins | 2 | 1997 | 804 | 0.090 |
Why?
|
| Coagulants | 1 | 2011 | 5 | 0.090 |
Why?
|
| Operon | 3 | 1997 | 34 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 111 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 106 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2012 | 435 | 0.090 |
Why?
|
| Antithrombins | 1 | 2011 | 20 | 0.090 |
Why?
|
| A549 Cells | 2 | 2022 | 53 | 0.090 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 61 | 0.090 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 65 | 0.090 |
Why?
|
| Trypsin | 3 | 2008 | 92 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2008 | 403 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 488 | 0.080 |
Why?
|
| Longevity | 1 | 2011 | 64 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2013 | 212 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1130 | 0.080 |
Why?
|
| Metals | 1 | 2011 | 104 | 0.080 |
Why?
|
| Periplasm | 3 | 2000 | 4 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 435 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 1255 | 0.080 |
Why?
|
| Pigments, Biological | 1 | 2010 | 12 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2011 | 179 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 1990 | 148 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2009 | 17 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 65 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2006 | 557 | 0.070 |
Why?
|
| Lysostaphin | 2 | 2006 | 2 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 1012 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 2002 | 209 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1324 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 527 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 5 | 1997 | 911 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2008 | 55 | 0.070 |
Why?
|
| DNA Primers | 3 | 2006 | 530 | 0.070 |
Why?
|
| Myocardium | 1 | 2011 | 578 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1251 | 0.070 |
Why?
|
| Heme | 2 | 2010 | 66 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 1604 | 0.070 |
Why?
|
| Phenotype | 3 | 2005 | 2638 | 0.070 |
Why?
|
| Crystallography, X-Ray | 4 | 2015 | 530 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 780 | 0.060 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2006 | 26 | 0.060 |
Why?
|
| Complement C1q | 1 | 2026 | 13 | 0.060 |
Why?
|
| Yersinia enterocolitica | 1 | 2006 | 18 | 0.060 |
Why?
|
| Halogenation | 1 | 2026 | 9 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2021 | 61 | 0.060 |
Why?
|
| Phagosomes | 1 | 2006 | 41 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2854 | 0.060 |
Why?
|
| Carbohydrate Epimerases | 2 | 2014 | 4 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2017 | 75 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 1996 | 273 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2008 | 489 | 0.060 |
Why?
|
| DNA Replication | 1 | 2006 | 169 | 0.060 |
Why?
|
| Protein Denaturation | 4 | 1992 | 110 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2017 | 251 | 0.050 |
Why?
|
| Methionine | 1 | 2004 | 64 | 0.050 |
Why?
|
| Glycine | 1 | 2004 | 96 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2004 | 60 | 0.050 |
Why?
|
| Dithiothreitol | 3 | 2007 | 25 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 174 | 0.050 |
Why?
|
| Maltose-Binding Proteins | 2 | 2000 | 31 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2023 | 94 | 0.050 |
Why?
|
| Denmark | 1 | 2022 | 20 | 0.050 |
Why?
|
| London | 1 | 2022 | 15 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2022 | 13 | 0.050 |
Why?
|
| Soil | 1 | 2023 | 55 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2022 | 84 | 0.050 |
Why?
|
| Biotechnology | 1 | 2022 | 30 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 253 | 0.040 |
Why?
|
| Enzymes | 1 | 2002 | 47 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 1994 | 548 | 0.040 |
Why?
|
| Virus Inactivation | 1 | 2021 | 4 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 18 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2022 | 74 | 0.040 |
Why?
|
| Semiconductors | 1 | 2021 | 11 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 18 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2022 | 38 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2021 | 14 | 0.040 |
Why?
|
| Vero Cells | 1 | 2022 | 98 | 0.040 |
Why?
|
| Europe | 1 | 2022 | 355 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2002 | 123 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 74 | 0.040 |
Why?
|
| Crystallization | 1 | 2002 | 219 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1231 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 110 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2022 | 73 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 120 | 0.040 |
Why?
|
| RNA, Bacterial | 2 | 2008 | 101 | 0.040 |
Why?
|
| Joints | 1 | 2020 | 34 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 522 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 161 | 0.040 |
Why?
|
| Light | 1 | 2021 | 290 | 0.040 |
Why?
|
| ATP-Dependent Proteases | 2 | 1996 | 5 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 260 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2000 | 55 | 0.040 |
Why?
|
| Piperidines | 1 | 2021 | 172 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 291 | 0.040 |
Why?
|
| Type III Secretion Systems | 1 | 2019 | 4 | 0.040 |
Why?
|
| U937 Cells | 1 | 2019 | 32 | 0.040 |
Why?
|
| Vitreous Body | 1 | 2019 | 52 | 0.040 |
Why?
|
| Rickettsia Infections | 1 | 2019 | 2 | 0.040 |
Why?
|
| Rickettsia | 1 | 2019 | 3 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 62 | 0.040 |
Why?
|
| Kidney Diseases | 2 | 2012 | 314 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2019 | 54 | 0.040 |
Why?
|
| Endothelium | 1 | 2019 | 63 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 316 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 382 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2019 | 77 | 0.040 |
Why?
|
| Keratitis | 1 | 2019 | 12 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 102 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2019 | 153 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1997 | 119 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 113 | 0.040 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2018 | 1 | 0.030 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2018 | 2 | 0.030 |
Why?
|
| Galactosidases | 1 | 2018 | 13 | 0.030 |
Why?
|
| Swine | 1 | 2019 | 593 | 0.030 |
Why?
|
| Lactococcus lactis | 1 | 2018 | 5 | 0.030 |
Why?
|
| Rats | 2 | 2018 | 4071 | 0.030 |
Why?
|
| Cefotaxime | 1 | 2017 | 6 | 0.030 |
Why?
|
| Ceftriaxone | 1 | 2017 | 11 | 0.030 |
Why?
|
| Protein Domains | 1 | 2018 | 168 | 0.030 |
Why?
|
| Lac Operon | 2 | 1996 | 43 | 0.030 |
Why?
|
| Splanchnic Circulation | 1 | 2017 | 14 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 802 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 304 | 0.030 |
Why?
|
| Puromycin | 1 | 1996 | 5 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2023 | 2525 | 0.030 |
Why?
|
| Concanavalin A | 1 | 1996 | 46 | 0.030 |
Why?
|
| Biofilms | 1 | 2017 | 52 | 0.030 |
Why?
|
| Cytochromes | 1 | 1997 | 60 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 1993 | 2060 | 0.030 |
Why?
|
| Gene Library | 1 | 1997 | 125 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 1097 | 0.030 |
Why?
|
| Protease La | 1 | 1996 | 4 | 0.030 |
Why?
|
| Cytochrome c Group | 1 | 1996 | 82 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1997 | 118 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 1996 | 31 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 1996 | 30 | 0.030 |
Why?
|
| Detergents | 1 | 1996 | 32 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 179 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1995 | 83 | 0.030 |
Why?
|
| Circular Dichroism | 2 | 1995 | 118 | 0.030 |
Why?
|
| Hemoglobins | 2 | 2010 | 198 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1159 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1997 | 305 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1996 | 122 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2015 | 17 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 2015 | 19 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 915 | 0.030 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2015 | 27 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 164 | 0.030 |
Why?
|
| Bacteriophage P1 | 1 | 1995 | 1 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 65 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2014 | 9 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1403 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 142 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 707 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2014 | 7 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2015 | 136 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2014 | 92 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 1 | 1993 | 23 | 0.020 |
Why?
|
| Kanamycin Resistance | 1 | 1993 | 2 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 524 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 126 | 0.020 |
Why?
|
| beta-Alanine | 1 | 2013 | 5 | 0.020 |
Why?
|
| Bacterial Load | 1 | 2013 | 20 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 157 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 218 | 0.020 |
Why?
|
| Dabigatran | 1 | 2013 | 25 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1993 | 239 | 0.020 |
Why?
|
| Central Venous Catheters | 1 | 2013 | 24 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1992 | 39 | 0.020 |
Why?
|
| beta-Lactamases | 1 | 1993 | 58 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2013 | 65 | 0.020 |
Why?
|
| Guanidines | 1 | 1992 | 34 | 0.020 |
Why?
|
| Guanidine | 1 | 1992 | 17 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 639 | 0.020 |
Why?
|
| RNA Precursors | 1 | 1993 | 75 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2012 | 47 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 151 | 0.020 |
Why?
|
| Drosophila | 1 | 1997 | 547 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2440 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2012 | 126 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2013 | 117 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2012 | 94 | 0.020 |
Why?
|
| Norfloxacin | 1 | 2012 | 3 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 889 | 0.020 |
Why?
|
| Siderophores | 1 | 2012 | 21 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1992 | 274 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2011 | 64 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2555 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2010 | 35 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 48 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 312 | 0.020 |
Why?
|
| Farnesyl-Diphosphate Farnesyltransferase | 1 | 2010 | 5 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 238 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 481 | 0.020 |
Why?
|
| Tryptophan | 1 | 1990 | 107 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 53 | 0.020 |
Why?
|
| Male | 3 | 2019 | 46983 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 2009 | 16 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 353 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 373 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1990 | 327 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 103 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 105 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 74 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1989 | 271 | 0.020 |
Why?
|
| United States | 1 | 2022 | 8155 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 129 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 285 | 0.020 |
Why?
|
| Ketones | 1 | 2007 | 15 | 0.020 |
Why?
|
| Alkenes | 1 | 2007 | 17 | 0.020 |
Why?
|
| Aprotinin | 2 | 1998 | 24 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1255 | 0.020 |
Why?
|
| Drug Design | 1 | 2007 | 135 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 700 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1814 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 116 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 669 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 1566 | 0.010 |
Why?
|
| Biological Transport | 1 | 2003 | 401 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 9689 | 0.010 |
Why?
|
| Horses | 2 | 1990 | 35 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1997 | 128 | 0.010 |
Why?
|
| Nitrate Reductase | 1 | 1996 | 2 | 0.010 |
Why?
|
| Nitrate Reductases | 1 | 1996 | 2 | 0.010 |
Why?
|
| Nitrite Reductases | 1 | 1996 | 2 | 0.010 |
Why?
|
| Anaerobiosis | 1 | 1996 | 21 | 0.010 |
Why?
|
| Point Mutation | 1 | 1997 | 237 | 0.010 |
Why?
|
| Copper | 1 | 1996 | 81 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1995 | 24 | 0.010 |
Why?
|
| Biopolymers | 1 | 1995 | 29 | 0.010 |
Why?
|
| Glutathione | 1 | 1995 | 108 | 0.010 |
Why?
|
| Catalysis | 1 | 1995 | 216 | 0.010 |
Why?
|
| Adhesins, Escherichia coli | 1 | 1993 | 3 | 0.010 |
Why?
|
| Chaperonins | 1 | 1993 | 10 | 0.010 |
Why?
|
| Integration Host Factors | 1 | 1993 | 11 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 1993 | 15 | 0.010 |
Why?
|
| Insulin | 1 | 1997 | 1226 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1996 | 1086 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1989 | 64 | 0.000 |
Why?
|
| Muscles | 1 | 1988 | 179 | 0.000 |
Why?
|
| Genetic Engineering | 1 | 1988 | 102 | 0.000 |
Why?
|
| Gene Expression | 1 | 1989 | 1320 | 0.000 |
Why?
|